{"date": "2022-01-10 15:17:39.649000+00:00", "ticker": "III", "mrkt_info": {"open": 1414.0, "close": 1434.5}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-lead\">\n<p>RNS Number : 9710XJPMorgan Claverhouse IT PLC10 January 2022</p>\n</div>\n<div class=\"tr-npp-body\">\n<p>\n<span>JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC</span>\n</p>\n<p>\n<span>(the 'Company')</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>LONDON STOCK EXCHANGE ANNOUNCEMENT</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>NOTIFICATION OF CROSS HOLDING</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>Legal Entity Identifier: 549300NFZYYFSCD52W53</span>\n</p>\n<p>\n<span>Information disclosed in accordance with Listing Rule 15.6.8</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>In accordance with Listing Rule 15.6.8 the Company confirms that, as at the close of business on 31st December 2021, it had a portfolio investment in</span>\n<span>3i Group plc,</span>\n<span>a company which does not itself have an investment policy that limits its investments in other listed closed-ended investment funds to no more than 15% of its total assets.</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>JPMorgan Funds Limited</span>\n</p>\n<p>\n<span>Company Secretary</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>10 <span>th</span> January 2022</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>For further information, please contact:</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>Nira Mistry</span>\n</p>\n<p>\n<span>JPMorgan Funds Limited 020 7742 4000</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact <a href=\"mailto:rns@lseg.com\" data-type=\"email\" translate=\"no\">rns@lseg.com</a> or visit <a href=\"http://www.rns.com/\" data-type=\"url\" class=\"tr-link\" translate=\"no\">www.rns.com</a> .RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our <a href=\"https://www.lseg.com/privacy-and-cookie-policy\" data-type=\"url\" class=\"tr-link\" translate=\"no\">Privacy Policy</a> .END</p>\n<p>PFUURRVRUSUAAAR</p>\n</div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright (c) 2022 Thomson Reuters Limited.</p></div>"}